ARTICLE SUMMARY:
MDR implementation strategies; Johnson & Johnson tests real-world evidence; FDA approvals down, but Shuren upbeat. These stories and more in the current issue of Market Pathways, your source for global medical device regulatory, reimbursement, and policy intelligence and analysis.